The National Institutes of Health (NIH) intends to award a non-competitive contract to Cellaven for a NESTOR Cell Automation Dispensing Unit, a specialized system for automated, sterile cell culture of sensitive iPSC lines. The procurement is conducted under simplified acquisition procedures and will not exceed the simplified acquisition threshold of $350,000. The required system is uniquely capable of meeting the government’s needs for precise, reproducible iPSC culture conditions, with Cellaven identified as the only responsible source. Performance of services will be at the NIH location in Bethesda, Maryland. Interested parties must submit capability statements by May 26, 2026, to be considered for a potential competitive procurement.